• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.

  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

(2024) Advancing Toxicity Research with 3D Tissue Models and Novel Imaging Techniques

On-demand Webinar


In the last 15 years, there have been tremendous developments in microphysiological systems (MPS) exhibiting in vivo-like functions and toxic drug responses. A high-throughput and scalable platform, enabling multiple replicates to be run in parallel, and that is compatible with high content imaging, is required to draw meaningful conclusions about toxicity.

Join Dr. Oksana Sirenko (Molecular Devices) and Dr. Kristin Bircsak (MIMETAS) as they share insights into three reproducible and comprehensive 3D tissue models (intestine, vasculature, and liver) and their toxic responses to drug and inflammatory mediators using media sampling and imaging-based readouts.


In this webinar, you will:

  • Learn how to scale up high-throughput workflows by leveraging the OrganoPlate® platform's compatibility with high-content imaging
  • Explore how to create disease-related 3D model workflows for screening and drug discovery
  • Discover how automation can increase the efficiency and productivity of tedious 3D drug screening workflows

 

Access the recording here!

 

Find out more about Molecular Devices!


 

 

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all